Skip to main content

WEED · Canopy Growth Corp · Documents

0.9200 CAD -0.0300 (-3.16%) At close · Nov 6 Intraday price with Plus

The company's reports, filings, earnings calls and investor events, most recent first. Search these from Claude or ChatGPT →

Annual report FY2026 Revenue 284.6M CAD up 5.8% 10-K filed Jun 15, 2026 Quarterly report New FY2027 Q2 Revenue 81.37M CAD up 22.0% 10-Q filed Nov 6, 2026 Latest results New Revenue rises 22% as international cannabis grows 141% 8-K filed Nov 6, 2026 Earnings call Q1 2027 earnings call Held Aug 7, 2026
2026
Nov 6
Current report 8-K
Revenue rises 22% as international cannabis grows 141%

Canopy Growth reported $81.4M in Q2 FY2027 net revenue, up 22%, with international markets cannabis revenue rising 141% to $12.3M. Cannabis segment revenue reached $66.2M, up 30%, while adjusted EBITDA loss improved to $2.9M.

Financial results
5 source passages
Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced its financial results for the three months ended September 30, 2026 ("Q2 FY2027"). Consolidated net revenue of $81.4M in Q2 FY2027 increased by 22% compared to the three months ended September 30, 2025 (“Q2 FY2026”). Cannabis net revenue was $66.2M in Q2 FY2027, an increase of 30% versus the prior-year period. International markets cannabis net revenue of $12.3M in Q2 FY2027 increased 141% as compared to $5.1 million in Q2 FY2026, primarily due to strong sales in Europe, specifically in Germany and Poland. Adjusted EBITDA loss for Q2 FY2027 was $2.9M, an improvement of $0.2M or 6% compared to Q2 FY2026, primarily attributable to revenue growth across the Cannabis segment and continued cost savings, partially offset by the reduction in the VAC reimbursement rate available for medical cannabis. Open the document at this passage
Nov 6
Quarterly report 10-Q FY2027 Q2, ended Sep 30
Canopy USA deconsolidated, leaving indirect U.S. market exposure

Canopy Growth deconsolidated Canopy USA effective April 30, 2024 and retains a non-controlling interest in the independently operated company, which holds interests in Acreage, Wana and Jetty.

Revenue 81.37M CAD ▲ 22.0% Net loss 40.69M CAD Diluted EPS -0.10 CAD
Read from the MD&A section
6 source passages
As of April 30, 2024, Canopy Growth has deconsolidated the financial results of Canopy USA and has a non-controlling interest in Canopy USA as of such date. Canopy USA was determined to be a variable interest entity pursuant to ASC 810 - Consolidations (“ASC 810”). Canopy USA and certain entities controlled by Canopy USA (the “Canopy USA LPs”) currently hold an ownership interest in the following assets, among others: Wana – Canopy USA holds 100% of the membership interests of Mountain High Products, LLC, Wana Wellness, LLC and The Cima Group, LLC (collectively, “Wana”), a leading cannabis edibles brand in North America. Jetty – Canopy USA holds approximately 77% of the shares of Jetty, a California-based producer of high-quality cannabis extracts and pioneer of clean vape technology. Acreage – Canopy USA holds 100% of the issued and outstanding shares of Acreage, a vertically-integrated multi-state cannabis operator, with its main operations in densely populated states across the Northeast U.S., including New Jersey and New York. Open the document at this passage
Nov 6
Report SEDAR+
MD&A
Oct 23
Current report 8-K
Shareholder vote results

At its October 23, 2026 annual meeting, Canopy Growth shareholders elected five directors, appointed MNP, and approved a share consolidation at a Board-determined ratio ranging from one post-consolidation share for every five to fifteen outstanding pre-consolidation shares.

Oct 16
Proxy statement DEFA14A
Proxy statement

Canopy Growth received a Nasdaq notice on October 14, 2026 that its common shares no longer comply with the $1.00 Minimum Bid Price Requirement and has until April 12, 2027 to regain compliance, with a Share Consolidation proposal up for vote at the reconvened Annual Meeting on October 23, 2026.

Oct 16
Current report 8-K Events of Oct 14
Delisting notice or listing transfer

Canopy Growth Corporation received notice from Nasdaq on October 14, 2026 that it is not in compliance with Nasdaq Listing Rule 5450(a)(1), as its common shares traded below $1.00 for 30 consecutive business days, giving it until April 12, 2027 to regain compliance.

Oct 6
Proxy statement DEFA14A
Proxy statement

Canopy Growth Corporation adjourned its September 25th shareholder meeting for lack of quorum and reconvened it October 23, 2026 at 1:00 p.m. (ET), with votes due by 9:00 a.m. (ET) to reach quorum and avoid further adjournment.

Sep 25
Proxy statement DEFA14A
Proxy statement

Canopy Growth adjourned its September 25, 2026 meeting because quorum was not present. It will reconvene October 23, 2026, at 1:00 p.m. ET, with voting by 9:00 a.m. ET, when 33 1/3% of outstanding Shares is required.

Aug 7
Proxy statement DEF 14A Meeting Sep 25, 2026
Proxy statement AI summary on its way
Aug 7
Quarterly report 10-Q FY2027 Q1, ended Jun 30
Quarterly report for FY2027 Q1 AI summary on its way
Revenue 81.17M CAD ▲ 12.5% Net loss 14.58M CAD Diluted EPS -0.03 CAD
Aug 7
Report SEDAR+
MD&A
Showing 1–50 of 1,303 documents